Danielle N. Margalit

Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma

Jonathan D. Schoenfeld, Glenn J. Hanna, Vickie Y. Jo et al. · JAMA Oncology · 2020 · 347 citations · Full text

Medicine, Immunology, Oncology +17

Incidence and Demographic Burden of HPV-Associated Oropharyngeal Head and Neck Cancers in the United States

Brandon A. Mahal, Paul J. Catalano, Robert I. Haddad et al. · Cancer Epidemiology Biomarkers & Prevention · 2019 · 230 citations

Medicine, Oncology, Cancer Control +15

Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement

David Thomson, David A. Palma, Matthias Gückenberger et al. · International Journal of Radiation Oncology*Biology*Physics · 2020 · 211 citations · Full text

Medicine, Oncology, Radiation Oncology +13

Targeting cell division: Small-molecule inhibitors of FtsZ GTPase perturb cytokinetic ring assembly and induce bacterial lethality

Danielle N. Margalit, Laura Romberg, Rebecca B. Mets et al. · Proceedings of the National Academy of Sciences · 2004 · 204 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

A Randomized Phase 2 Study of Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma

Umair Mahmood, Andrew Bang, Yu‐Hui Chen et al. · International Journal of Radiation Oncology*Biology*Physics · 2020 · 110 citations · Full text

Medicine, Oncology, Radiation Oncology +8